NIPH Clinical Trials Search

Basic Information

Recruitment status	completed
Health condition(s) or Problem(s) studied
Date of first enrollment	10/01/2017
Target sample size	455
Countries of recruitment	Japan
Study type	Interventional
Intervention(s)	investigational material(s) Generic name etc : INN of investigational material : semaglutide Therapeutic category code : 249 Other hormone preparations (including antihormone preparations) Dosage and Administration for Investigational material : control material(s) Generic name etc : INN of investigational material : Dulaglutide Therapeutic category code : 249 Other hormone preparations (including antihormone preparations) Dosage and Administration for Investigational material :

Outcome(s)

Primary Outcome	safety
Secondary Outcome	safety efficacy

Key inclusion & exclusion criteria

Age minimum	>= 20age old
Age maximum	Not applicable
Gender	Both
Include criteria
Exclude criteria